Overcoming structural barriers to tuberculosis treatment in Africa through digital technologies

The Lancet Microbe 2026 Open access

Read full text
Authors: Tsegahun Manyazewal, Russell Ryan Kempker, Zelalem Temesgen, Catherine Orrell, Esther Stanslaus Ngadaya, Angella Musiimenta, Lilian N. Njagi, Priashni Subrayen, Yimtubezinash Woldeamanuel, Hussen Mohammed, Abebaw Fekadu, Melanie J. Newport
+1 more Vincent C. Marconi
DOI: 10.1016/j.lanmic.2026.101399
Cited by: 0
References: 9

Abstract

Millions of people still die from tuberculosis in Africa. The continent is home to 17 of the 30 countries with the highest tuberculosis burdens and 25% of all new cases worldwide. According to the WHO Global Tuberculosis Report 2025,1 the continent exceeded the first End TB Strategy milestones and recorded one of the strongest global recoveries in tuberculosis control; the efforts of African governments and their international partners have been instrumental in this progress. Despite these advances, the continent is still struggling with monitoring tuberculosis treatment adherence and completion, which directly affects cure, relapse, drug resistance, transmission dynamics, and economic wellbeing.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Mobile Health and mHealth Applications Telemedicine and Telehealth Implementation

Publication details

Journal / source
The Lancet Microbe
Volume
7
Issue
6
Pages
101399–101399
Publication date
13 March 2026
Language
EN